116 related articles for article (PubMed ID: 1289988)
21. Monoclonal antibodies from mice bearing human colorectal carcinoma xenografts.
Sikora K; Warenius H
Med Oncol Tumor Pharmacother; 1986; 3(1):5-9. PubMed ID: 3702511
[TBL] [Abstract][Full Text] [Related]
22. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
[No Abstract] [Full Text] [Related]
23. The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics.
Korver W; Singh S; Liu S; Zhao X; Yonkovich S; Sweeney A; Anton K; Lomas WE; Greenwood R; Smith A; Tran DH; Shinkawa P; Jimenez M; Yeung P; Aguilar G; Palencia S; Vatta P; Mueller M; Zhan X; Newton EM; Liu Y; Zhao J; Emtage P; Levy MD; Hsi ED; Funk WD; Abo A
Br J Haematol; 2007 May; 137(4):307-18. PubMed ID: 17456053
[TBL] [Abstract][Full Text] [Related]
24. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
Hamano T; Asofsky R
J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
[TBL] [Abstract][Full Text] [Related]
25. A novel human monoclonal antibody rapidly induces homotypic cell aggregation and promotes antibody-secreting activity by human B lymphoblastoid cell line IM-9.
Ikewaki N
J Clin Immunol; 1997 Mar; 17(2):127-39. PubMed ID: 9083889
[TBL] [Abstract][Full Text] [Related]
26. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
[TBL] [Abstract][Full Text] [Related]
27. G10.3 monoclonal antibody identifies novel functional cell surface structures expressed by normal B lymphocytes and various malignant cell lines.
Schiavon V; Elhabazi A; Agrawal S; Tawab A; Nikolova M; Boumsell L; Bensussan A
Tissue Antigens; 1999 Jan; 53(1):23-32. PubMed ID: 10082428
[TBL] [Abstract][Full Text] [Related]
28. Functional studies on B cell hybridomas with B cell surface antigens. IV. Direct effects of cytochalasin B on differentiation.
Hamano T; Asofsky R
J Immunol; 1984 Jan; 132(1):122-8. PubMed ID: 6418794
[TBL] [Abstract][Full Text] [Related]
29. Human hybridomas derived from CD5+ B lymphocytes of patients with chronic lymphocytic leukemia (B-CLL) produce multi-specific natural IgM (kappa) antibodies.
Jahn S; Schwab J; Hansen A; Heider H; Schroeder C; Lukowsky A; Achtman M; Matthes H; Kiessig ST; Volk HD
Clin Exp Immunol; 1991 Mar; 83(3):413-7. PubMed ID: 1706236
[TBL] [Abstract][Full Text] [Related]
30. [Hybridomas synthesizing monoclonal antibodies to surface antigens of human lymphocytes].
Seregina TM; Mekshenkov MI
Tsitologiia; 1986 Sep; 28(9):976-80. PubMed ID: 3798564
[TBL] [Abstract][Full Text] [Related]
31. Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.
Chen PF; Freedman RS; Chernajovsky Y; Platsoucas CD
Hum Antibodies Hybridomas; 1994; 5(3-4):131-42. PubMed ID: 7756578
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
33. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique.
Yoshikawa K; Ueda R; Obata Y; Utsumi KR; Notake K; Takahashi T
Jpn J Cancer Res; 1986 Nov; 77(11):1122-33. PubMed ID: 3098722
[TBL] [Abstract][Full Text] [Related]
34. Mouse monoclonal antibodies against the idiotype of human B cell non-Hodgkin lymphomas: production, characterization and use to monitor the progress of disease.
Rankin EM; Hekman A
Eur J Immunol; 1984 Dec; 14(12):1119-26. PubMed ID: 6394351
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1987 Sep; 108(2):313-22. PubMed ID: 3113742
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity of mixed human monoclonal antibodies reacting to tumor antigens.
Hagiwara H; Aotsuka Y
Acta Paediatr Jpn; 1987 Aug; 29(4):552-6. PubMed ID: 3144890
[No Abstract] [Full Text] [Related]
37. Monoclonal anticolon carcinoma antibodies in complement-dependent cytotoxicity.
Herlyn DM; Koprowski H
Int J Cancer; 1981 Jun; 27(6):769-74. PubMed ID: 7287228
[TBL] [Abstract][Full Text] [Related]
38. Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cells.
Link BK; Weiner GJ
Blood; 1993 Jun; 81(12):3343-9. PubMed ID: 8507872
[TBL] [Abstract][Full Text] [Related]
39. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
40. A human monoclonal antibody recognizing a surface antigen on stomach cancer cells.
Yoshikawa K; Furukawa K; Ueda R; Iwasa S; Lloyd KO; Notake K; Takahashi T
Jpn J Cancer Res; 1989 Jun; 80(6):546-53. PubMed ID: 2474525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
